Anti-FLT3 CAR T-cells have been shown to kill FLT3+ cell lines and AML patient bone marrow mononuclear cells in vitro with more potency in FLT3-ITD cells with an effector to target (E:T) ratio of as low as 1:8 (34). Here, FLT3 is linked to acute myeloid leukemia.